TPST
Tempest Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD1.10
+0.01 (+0.45%)
Rating:D+
Company Profile
CEO
Matthew Angel
IPO Date
2012-11-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.07
Prev. Close
$1.10
Day Low
$1.07
Day High
$1.12
52W Low
$1.02
52W High
$12.23
Market Cap
$0.00B
Volume
0.01M